菊苣根多糖脂质体的优化及其在新城疫疫苗接种中的佐剂效果
本研究分离菊苣根多糖(CP),优化菊苣根多糖脂质体(CPL)制备条件并评价其免疫活性。CP多糖含量为89.45±1.25%,分子量2.72 kDa;CPL最佳制备条件为磷脂与胆固醇比5:1、磷脂与菊苣多糖比9:1、旋转蒸发温度31°C,平均包封率61.53±0.19%。CP和CPL均能促进鸡脾淋巴细胞增殖,CPL在更低浓度下即可增强增殖,体内试验中CPL组HI抗体效价显著高于VC组,提示CPL可作为新型疫苗稀释剂或免疫佐剂。
要点
- CPL最佳制备条件:磷脂胆固醇比5:1、磷脂多糖比9:1、蒸发温度31°C。
- CPL平均包封率61.53±0.19%,粒径86.96±0.98 nm,PDI 0.187±0.008。
- CPL在更低浓度下即可促进鸡脾淋巴细胞增殖,免疫刺激效率优于CP。
核心结论
- CPL可作为新型疫苗稀释剂或免疫佐剂。
研究设计与样本
- 分离菊苣根多糖(CP),优化菊苣根多糖脂质体(CPL)制备条件,并评价其免疫活性。
主要发现
- CP多糖含量为89.45±1.25%,分子量2.72 kDa。
- CPL平均包封率61.53±0.19%,平均粒径86.96±0.98 nm,PDI 0.187±0.008,Zeta电位-15.40±1.23 mV。
- CP和CPL显著促进鸡脾淋巴细胞、脾T淋巴细胞和B淋巴细胞增殖,CPL在更低浓度下增强淋巴细胞增殖。
- 体内试验第7-49天,CPLH、CPLM和CPLL组HI抗体效价显著高于VC组。
- CPLM组血清抗体效价在第35-49天显著或数值上高于CP组和VC组;IL-2和IL-4浓度在第14-49天显著高于VC组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study isolated chicory root polysaccharides (CP), optimized the preparation conditions of chicory root polysaccharides liposomes (CPL) and evaluated its effect on immune activity. The polysaccharide content and molecular weight of CP were 89.45 ± 1.25% and 2.72 kDa, respectively. The optimal preparation conditions of CPL were a phospholipid to cholesterol ratio of 5:1, a phospholipid-to-chicory polysaccharide ratio of 9:1, and a rotary evaporation temperature of 31 °C. The average encapsulation efficiency (EE) was 61.53 ± 0.19%, the average particle size, polymer dispersity index (PDI), and zeta potential were 86.96 ± 0.98 nm, 0.187 ± 0.008, and - 15.40 ± 1.23 mV, respectively. CP and CPL significantly promoted the proliferation of chicken splenic lymphocytes, splenic T and B lymphocytes at concentrations of 31.25-250 μg/mL and 7.813-31.25 μg/mL, 125-250 μg/mL and 1.953-31.25 μg/mL, 31.25-250 μg/mL and 15.625-31.25 μg/mL in vitro. CPL enhanced lymphocyte proliferation at substantially lower concentrations than CP, demonstrating superior immunostimulatory efficiency. In vivo, On days 7-49, HI(Hemagglutination Inhibition Antibody) antibody titers in the CPLH, CPLM and CPLL groups were significantly higher than those in the VC group. The serum antibody titers in the CPLM groups were significantly or numerically higher than both the CP and VC groups at days 35-49. The IL-2 and IL-4 concentrations in the CPLM group were significantly higher than those in the VC group on days 14-49. These findings suggest that CPL could serve as a novel vaccine diluent or immune adjuvant.
引用
- Tang Q, Li J, Hou C, et al. Optimization of chicory root polysaccharide liposomes and their adjuvant efficacy in Newcastle disease vaccination. Vaccine. 2026. PMID: 42167135. doi:10.1016/j.vaccine.2026.128734
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。